Jamieson Wellness Inc. (TSX:JWEL)
| Market Cap | 1.46B +9.3% |
| Revenue (ttm) | 845.84M +12.5% |
| Net Income | 73.69M +37.5% |
| EPS | 1.72 +39.2% |
| Shares Out | 41.48M |
| PE Ratio | 20.45 |
| Forward PE | 16.45 |
| Dividend | 0.84 (2.43%) |
| Ex-Dividend Date | May 30, 2025 |
| Volume | 175,216 |
| Average Volume | 98,956 |
| Open | 35.02 |
| Previous Close | 35.21 |
| Day's Range | 34.10 - 35.02 |
| 52-Week Range | 32.54 - 39.30 |
| Beta | 0.91 |
| RSI | 50.05 |
| Earnings Date | May 7, 2026 |
About Jamieson Wellness
Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells the natural health products for human in Canada, the United States, China, and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products, including vitamins, minerals, and supplements as well as sports nutrition products. The Strategic Partners segment provides contract manufacturing services to consu... [Read more]
Financial Performance
In 2025, Jamieson Wellness's revenue was 822.06 million, an increase of 12.03% compared to the previous year's 733.78 million. Earnings were 62.44 million, an increase of 20.27%.
Financial StatementsNews
Jamieson Wellness price target raised to C$44 from C$43 at CIBC
CIBC raised the firm’s price target on Jamieson Wellness (JWLLF) to C$44 from C$43 and keeps an Outperformer rating on the shares.
Q1 2026 Jamieson Wellness Inc Earnings Call Transcript
Q1 2026 Jamieson Wellness Inc Earnings Call Transcript
Jamieson Wellness Earnings Call Transcript: Q1 2026
Q1 2026 saw 16% revenue growth and 18% adjusted EBITDA growth, with strong performance across all markets, especially China. Full-year guidance was reaffirmed, and disciplined capital allocation continues, with inventory investments to support growth and mitigate risks.
Jamieson Wellness Inc. Reports First Quarter 2026 Results
TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) today reported its first quarter results for the period ended March 31, 2026. All amounts are expres...
Jamieson Wellness Inc. Announces Date of First Quarter 2026 Financial Results and Conference Call
TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX:JWEL) announced today that the Company will release its first quarter 2026 financial results after the mark...
Jamieson Wellness Inc. Announces Filing of Management Information Circular for Annual and Special Meeting of Shareholders
TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) announced today that the Company has filed its management information circular (“Circular”) and rela...
Jamieson Wellness initiated with an Outperformer at CIBC
CIBC analyst Ty Collin initiated coverage of Jamieson Wellness (JWLLF) with an Outperformer rating and C$43 price target Jamieson is a “leader” in the “attractive” vitamin, mineral, and supplement ind...
Jamieson Wellness price target raised to C$45 from C$42 at Stifel
Stifel raised the firm’s price target on Jamieson Wellness (JWLLF) to C$45 from C$42 and keeps a Buy rating on the shares.
Jamieson Wellness Earnings Call Transcript: Q4 2025
Delivered 12% annual revenue growth and strong Q4 results, led by China and innovation across key markets. 2026 guidance calls for 9–14% revenue growth, stable margins, and continued investment in marketing and product development.
Jamieson Wellness Inc. Reports Fourth Quarter and Full Year 2025 Results
TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) today reported financial results for its fourth quarter and full year ended December 31, 2025. All a...
Jamieson Wellness Inc. Announces Renewal of Normal Course Issuer Bid
TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) announced today that it has received approval from the Toronto Stock Exchange (the “TSX”) to renew i...
Jamieson Wellness price target raised to C$44 from C$43 at RBC Capital
RBC Capital analyst Ryland Conrad raised the firm’s price target on Jamieson Wellness (JWLLF) to C$44 from C$43 and keeps an Outperform rating on the shares.
Jamieson Wellness Inc. Announces Date of Fourth Quarter and Full Year 2025 Financial Results and Conference Call
TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX:JWEL) announced today that the Company will release its fourth quarter and full year 2025 financial results...
Jamieson Wellness Earnings Call Transcript: Q3 2025
Q3 saw 13.2% revenue growth, led by 16.5% branded gains and over 60% growth in China. Guidance for 2025 was raised for branded segments, with strong innovation and digital marketing driving results. Gross margin expanded 350 bps, and no consumer trade-down was observed.
Jamieson Wellness Inc. Reports Third Quarter 2025 Results
TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) today reported its third quarter results for the period ended September 30, 2025. All amounts are ex...
Jamieson Wellness Inc. Announces Date of Third Quarter 2025 Financial Results and Conference Call
TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX:JWEL) announced today that the Company will release its third quarter 2025 financial results after the mark...
Jamieson Wellness Inc. Announces Appointment of New Board Director
TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX:JWEL) announced today the appointment of Gayle Tait to the Company's Board of Directors. “The VMS marketpla...
Jamieson Wellness Earnings Call Transcript: Q2 2025
Q2 2025 saw 7.7% revenue growth, led by strong branded segment gains in China and the U.S., improved margins, and robust cash flow. Guidance for 2025 was raised for China, with strategic partner outlook lowered due to tariff-related delays. Dividend increased by 9.5%.
Jamieson Wellness Inc. Reports Second Quarter 2025 Results
TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) today reported its second quarter results for the period ended June 30, 2025. All amounts are expres...
Jamieson Wellness Inc. Announces Date of Second Quarter 2025 Financial Results and Conference Call
TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX:JWEL) announced today that the Company will release its second quarter 2025 financial results after the mar...
Jamieson Wellness Inc. Announces Voting Results from 2025 Annual Meeting of Shareholders
TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) announced today that each of the nominee directors listed in the management informat...
Jamieson Wellness Inc. Announces Redemption of Series A Preference Shares
TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) today announced that it will redeem its outstanding 2,527,121 Series A Preference Shares (the “Prefe...
Jamieson Wellness Earnings Call Transcript: Q1 2025
Q1 2025 saw 14% revenue growth, strong gains in China and international markets, and improved margins. Guidance for 2025 is maintained, with continued investment in innovation, digital, and operational efficiency. Share buybacks and dividends remain key capital priorities.
Jamieson Wellness Inc. Reports First Quarter 2025 Results
TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) today reported its first quarter results for the period ended March 31, 2025. All amounts are expres...
Jamieson Wellness Inc. Announces Date of First Quarter 2025 Financial Results and Conference Call
TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX:JWEL) announced today that the Company will release its first quarter 2025 financial results after the mark...